Search results
Oct 13, 2021 · Its three founders — Josh Hoffman, Zach Serber and Jed Dean — posed in front of the screen, smiling beneath their pandemic masks emblazoned with the yellow Zymergen logo.
Zymergen was founded in 2013. [5] by investment banker Joshua Hoffman, biophysicist Zach Serber, and biochemist Jed Dean. [6] All three met while working at Amyris, Inc. [7] The company uses machine learning and artificial intelligence to study and modify microbes which ferment carbon [6] to produce chemicals used in manufacturing consumer ...
Apr 22, 2021 · Hoffman, 50, a former McKinsey consultant and Rothschild merchant banker, founded Zymergen in 2013 with two former Amyris execs, Zach Serber, 46, now chief science officer, and Jed Dean, 43,...
Oct 21, 2021 · Jed Dean, Zymergen Inc.'s co-founder, has notified the Company of his decision to step down effective as of October 31, 2021. Dr. Dean has been working with the Company to ensure a smooth transition of his responsibilities.
Vice President of Operations and Engineering. At Zymergen, Jed is responsible for building and operating the robotic workflows for genome engineering and high throughput screening.
View Jed Dean’s profile on LinkedIn, a professional community of 1 billion members. Experience: Advisor · Location: San Francisco Bay Area · 500+ connections on LinkedIn.
- 500+
- Advisor
- 1.7K
- San Francisco Bay Area
Dec 2, 2015 · Jed Dean—vice president of operations and engineering. Before joining Zymergen, Dean developed technology and automation at Amyris and at the Stanford Genome Technology Center. Aaron Kimball—chief technology officer. He is responsible for building the data architecture the company uses to facilitate a robotics-driven approach to genome ...
